Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2019-05-17 Capital/Financing Update
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). This type of filing is a formal regulatory disclosure of a capital-raising event, which falls under the 'Capital/Financing Update' category.
2019-05-17 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Cellumed' covering the period from January 1, 2019, to March 31, 2019. It contains detailed financial information, company history, capital changes, and business operations, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Korean
사업보고서 (2018.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Cellumed' (주식회사 셀루메드) for the fiscal year ending December 31, 2018. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes (주석). While it contains financial data, it is a formal audit report rather than a standalone annual report (10-K) or a simple earnings release. Given the specific category 'Audit Report / Information' (AR) exists, this is the most accurate classification. FY 2018
2019-04-01 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by the company Cellumed. It details the contract value, counterparty, duration, and payment terms. Since this is a specific regulatory disclosure regarding a business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2019-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official filing titled '정기주주총회결과' (Results of the Annual General Meeting) for the company Cellumed. It details the outcomes of the meeting held on March 27, 2019, including the approval of financial statements, dividend resolutions, and board appointments. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2019-03-27 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by Cellumed. It details the patent name, content, and utilization plan. Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a standard regulatory disclosure of corporate activity, it falls under the 'Regulatory Filings' category.
2019-03-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.